CLRPF
Price
$2.12
Change
+$0.10 (+4.95%)
Updated
Sep 4 closing price
Capitalization
771.57M
ENLV
Price
$1.06
Change
-$0.01 (-0.93%)
Updated
Sep 5 closing price
Capitalization
25.29M
86 days until earnings call
Interact to see
Advertisement

CLRPF vs ENLV

Header iconCLRPF vs ENLV Comparison
Open Charts CLRPF vs ENLVBanner chart's image
Clarity Pharmaceuticals
Price$2.12
Change+$0.10 (+4.95%)
Volume$13.37K
Capitalization771.57M
Enlivex Therapeutics
Price$1.06
Change-$0.01 (-0.93%)
Volume$185.74K
Capitalization25.29M
CLRPF vs ENLV Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. ENLV commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a StrongBuy and ENLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLRPF: $2.12 vs. ENLV: $1.06)
Brand notoriety: CLRPF and ENLV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 237% vs. ENLV: 27%
Market capitalization -- CLRPF: $771.57M vs. ENLV: $25.29M
CLRPF [@Biotechnology] is valued at $771.57M. ENLV’s [@Biotechnology] market capitalization is $25.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileENLV’s FA Score has 1 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • ENLV’s FA Score: 1 green, 4 red.
According to our system of comparison, ENLV is a better buy in the long-term than CLRPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 4 TA indicator(s) are bullish while ENLV’s TA Score has 6 bullish TA indicator(s).

  • CLRPF’s TA Score: 4 bullish, 6 bearish.
  • ENLV’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, ENLV is a better buy in the short-term than CLRPF.

Price Growth

CLRPF (@Biotechnology) experienced а +8.72% price change this week, while ENLV (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ENLV is expected to report earnings on Dec 01, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRPF($772M) has a higher market cap than ENLV($25.3M). ENLV YTD gains are higher at: -9.402 vs. CLRPF (-21.627). ENLV has higher annual earnings (EBITDA): -14.04M vs. CLRPF (-66.98M).
CLRPFENLVCLRPF / ENLV
Capitalization772M25.3M3,051%
EBITDA-66.98M-14.04M477%
Gain YTD-21.627-9.402230%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A20.6M-
Total DebtN/A503K-
FUNDAMENTALS RATINGS
ENLV: Fundamental Ratings
ENLV
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRPFENLV
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
67%
Bearish Trend 19 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUNR8.490.07
+0.83%
Intuitive Machines
AEP108.11-0.53
-0.49%
American Electric Power Company
SNBR9.67-0.06
-0.62%
Sleep Number Corp
VCTR71.45-0.86
-1.19%
Victory Capital Holdings
EBON3.88-0.22
-5.36%
Ebang International Holdings

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and ENLV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and ENLV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
N/A
ENLV - CLRPF
22%
Poorly correlated
-0.93%
JBPHF - CLRPF
14%
Poorly correlated
N/A
MLTX - CLRPF
11%
Poorly correlated
-0.47%
TELIF - CLRPF
10%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
-0.88%
More

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-0.93%
APVO - ENLV
36%
Loosely correlated
-1.23%
FENC - ENLV
26%
Poorly correlated
-1.96%
OCUL - ENLV
26%
Poorly correlated
+7.09%
JANX - ENLV
24%
Poorly correlated
+0.17%
KZIA - ENLV
24%
Poorly correlated
-4.08%
More